Terpenoid ID | TKC053930 | |
Cell line | 0 | |
Protein target | 11 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 14 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC053930 | HepG2 | 15.0 | % | Protection | C3728 | Orphanet_449 | |
TKC053930 | Hepatocyte | 24.0 | % | Activity | |||
TKC053930 | ECV-304 | ECV 304; ECV304; ECV; E304; T24(ECV304) | 119000.0 | nM | IC50 | C4912 | |
TKC053930 | MDCK | MDCK (NBL-2); NBL-2; Madin-Darby Canine Kidney; Madin Darby Canine Kidney | 15200.0 | nM | EC50 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC053930 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | >100000 | nM | IC50 |
TKC053930 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 12500 | nM | Ki |
TKC053930 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 15900 | nM | Ki |
TKC053930 | Q9UBT6 | DNA polymerase kappa | POLK | 31623 | nM | Potency |
TKC053930 | P25779 | Cruzipain | 3162 | nM | Potency | |
TKC053930 | P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | HSD11B1 | 6 | nM | IC50 |
TKC053930 | P04798 | Cytochrome P450 1A1 | CYP1A1 | 39 | % | Inhibition |
TKC053930 | Q16678 | Cytochrome P450 1B1 | CYP1B1 | 11 | % | Inhibition |
TKC053930 | P50172 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Hsd11b1 | 3 | nM | IC50 |
TKC053930 | O94956 | Solute carrier organic anion transporter family member 2B1 | SLCO2B1 | 29 | % | Inhibition |
TKC053930 | Q92887 | ATP-binding cassette sub-family C member 2 | ABCC2 | 5 | % | Activity |
TKC053930 | P00690 | Pancreatic alpha-amylase | AMY2 | >200000 | nM | IC50 |
TKC053930 | P46720 | Solute carrier organic anion transporter family member 1A1 | Slco1a1 | 52 | % | Activity |
TKC053930 | P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | HSD11B2 | 0 | nM | IC50 |
TKC053930 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 822000 | nM | IC50 |
TKC053930 | Q63120 | ATP-binding cassette sub-family C member 2 | Abcc2 | 1910 | nM | Ki |
TKC053930 | O35913 | Solute carrier organic anion transporter family member 1A4 | Slco1a4 | 47 | % | Activity |
TKC053930 | O88397 | Solute carrier organic anion transporter family member 1A5 | Slco1a5 | 51 | % | Activity |
TKC053930 | P09429 | High mobility group protein B1 | HMGB1 | 87000 | nM | Kd |
TKC053930 | P63158 | High mobility group protein B1 | Hmgb1 | 70 | uM | ED50 |
TKC053930 | Q9QZX8 | Solute carrier organic anion transporter family member 1B2 | Slco1b2 | 6100 | nM | Ki |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 | PTN1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P18031 | PTN1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 | PTN1_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P18031 | PTN1_HUMAN | Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 | PTN1_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 | PTN1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P25779 | CYSP_TRYCR | Parasitic worm infestation [ICD-11: 1F90] |
P25779 | CYSP_TRYCR | Malaria [ICD-11: 1F40-1F45] |
P28845 | DHI1_HUMAN | Influenza [ICD-11: 1E30-1E32] |
P28845 | DHI1_HUMAN | Lupus erythematosus [ICD-11: 4A40] |
P28845 | DHI1_HUMAN | Myasthenia gravis [ICD-11: 8C6Y] |
P28845 | DHI1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P28845 | DHI1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P28845 | DHI1_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P28845 | DHI1_HUMAN | Glaucoma [ICD-11: 9C61] |
P28845 | DHI1_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
P28845 | DHI1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P28845 | DHI1_HUMAN | Inborn lipid metabolism error [ICD-11: 5C52] |
P28845 | DHI1_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P80365 | DHI2_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |